WO2001047944A3 - Nucleic acids containing single nucleotide polymorphisms and methods of use thereof - Google Patents

Nucleic acids containing single nucleotide polymorphisms and methods of use thereof Download PDF

Info

Publication number
WO2001047944A3
WO2001047944A3 PCT/US2000/035498 US0035498W WO0147944A3 WO 2001047944 A3 WO2001047944 A3 WO 2001047944A3 US 0035498 W US0035498 W US 0035498W WO 0147944 A3 WO0147944 A3 WO 0147944A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
methods
nucleotide polymorphisms
acids containing
containing single
Prior art date
Application number
PCT/US2000/035498
Other languages
French (fr)
Other versions
WO2001047944A2 (en
Inventor
Richard A Shimkets
Martin Leach
Original Assignee
Curagen Corp
Richard A Shimkets
Martin Leach
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Richard A Shimkets, Martin Leach filed Critical Curagen Corp
Priority to AU29145/01A priority Critical patent/AU2914501A/en
Priority to CA002395926A priority patent/CA2395926A1/en
Priority to EP00993615A priority patent/EP1244688A1/en
Publication of WO2001047944A2 publication Critical patent/WO2001047944A2/en
Publication of WO2001047944A3 publication Critical patent/WO2001047944A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Abstract

The invention provides nucleic acids containing single-nucleotide polymorphisms identified for transcribed human sequences, as well as methods of using the nucleic acids.
PCT/US2000/035498 1999-12-28 2000-12-28 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof WO2001047944A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU29145/01A AU2914501A (en) 1999-12-28 2000-12-28 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
CA002395926A CA2395926A1 (en) 1999-12-28 2000-12-28 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
EP00993615A EP1244688A1 (en) 1999-12-28 2000-12-28 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17341999P 1999-12-28 1999-12-28
US60/173,419 1999-12-28

Publications (2)

Publication Number Publication Date
WO2001047944A2 WO2001047944A2 (en) 2001-07-05
WO2001047944A3 true WO2001047944A3 (en) 2003-02-20

Family

ID=22631931

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/035498 WO2001047944A2 (en) 1999-12-28 2000-12-28 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof

Country Status (3)

Country Link
AU (1) AU2914501A (en)
CA (1) CA2395926A1 (en)
WO (1) WO2001047944A2 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7258860B2 (en) 1998-03-18 2007-08-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6960570B2 (en) 1998-03-18 2005-11-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6696247B2 (en) 1998-03-18 2004-02-24 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US20030083284A1 (en) * 2001-08-01 2003-05-01 Isis Pharmaceuticals Inc. Antisense modulation of p70 S6 kinase expression
US20030232056A1 (en) 1999-09-10 2003-12-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6710170B2 (en) 1999-09-10 2004-03-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
EP1308522A1 (en) * 2001-11-05 2003-05-07 Haferlach, Torsten, PD Dr. Dr. Novel genetic markers for leukemias
FR2836484B1 (en) * 2002-02-25 2005-02-04 Assist Publ Hopitaux De Paris METHOD OF IN VITRO DETECTION OF CANCERS BY THE EVIDENCE OF ALLELIC IMBALANCES OF INSERT-DELETION MARKERS
WO2003085378A2 (en) * 2002-04-03 2003-10-16 Syngenta Participations Ag Detection of wheat and barley fungal pathogens which are resistant to certain fungicides using the polymerase chain reaction
US7301017B2 (en) * 2002-05-30 2007-11-27 Kolesnick Richard N Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
CN1244375C (en) * 2003-01-03 2006-03-08 中国科学院上海生命科学研究院 Human liver regeneration related protein and its application
EP1911853A3 (en) * 2003-06-10 2011-11-16 bioMerieux B.V. Nucleic acid sequences that can be used as primers and probes in the amplification and detection of SARS coronavirus
US7871610B2 (en) 2003-08-12 2011-01-18 Dyax Corp. Antibodies to Tie1 ectodomain
US7485297B2 (en) 2003-08-12 2009-02-03 Dyax Corp. Method of inhibition of vascular development using an antibody
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
CN101313063B (en) * 2005-08-09 2013-04-03 肿瘤疗法·科学股份有限公司 Cancer-rejection antigen peptide derived from glypican-3 (GPC3) for use in HLA-A2-positive patient and pharmaceutical comprising the antigen
EP2041338A4 (en) * 2006-06-09 2009-09-30 Univ British Columbia Interferon gamma polymorphisms as indicators of subject outcome in critically ill subjects
GB2453589A (en) 2007-10-12 2009-04-15 King S College London Protease inhibition
FR2937322B1 (en) * 2008-10-22 2013-02-22 Vect Horus PEPTIDE DERIVATIVES AND THEIR USE AS VECTORS OF MOLECULES IN THE FORM OF CONJUGATES
US9890202B2 (en) 2010-07-19 2018-02-13 Yeda Research And Development Co. Ltd. Peptides based on the transmembrane domain of a toll-like receptor (TLR) for treatment of TLR-mediated diseases
GB201511546D0 (en) 2015-07-01 2015-08-12 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
EP3919507A3 (en) 2015-07-01 2022-01-12 Immatics Biotechnologies GmbH Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
WO2018115879A1 (en) 2016-12-21 2018-06-28 Mereo Biopharma 3 Limited Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
CA3061905A1 (en) * 2017-05-24 2018-11-29 The Regents Of The University Of California Antisense therapies for treating cancer
GB201714330D0 (en) * 2017-09-06 2017-10-18 Järver Peter Oligonucleotides

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992013069A1 (en) * 1991-01-21 1992-08-06 Imperial College Of Science, Technology & Medicine Test and model for alzheimer's disease
US5656477A (en) * 1992-05-01 1997-08-12 American Cyanamid Company Amyloid precursor proteins and method of using same to assess agents which down-regulate formation of β-amyloid peptide
WO1998020165A2 (en) * 1996-11-06 1998-05-14 Whitehead Institute For Biomedical Research Biallelic markers
US5795963A (en) * 1992-06-04 1998-08-18 Alzheimer's Institute Of America Amyloid precursor protein in alzheimer's disease
WO1998038846A2 (en) * 1997-03-07 1998-09-11 Affymetrix, Inc. Genetic compositions and methods

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992013069A1 (en) * 1991-01-21 1992-08-06 Imperial College Of Science, Technology & Medicine Test and model for alzheimer's disease
US5656477A (en) * 1992-05-01 1997-08-12 American Cyanamid Company Amyloid precursor proteins and method of using same to assess agents which down-regulate formation of β-amyloid peptide
US5795963A (en) * 1992-06-04 1998-08-18 Alzheimer's Institute Of America Amyloid precursor protein in alzheimer's disease
WO1998020165A2 (en) * 1996-11-06 1998-05-14 Whitehead Institute For Biomedical Research Biallelic markers
WO1998038846A2 (en) * 1997-03-07 1998-09-11 Affymetrix, Inc. Genetic compositions and methods

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FAN J ET AL: "Genetic mapping: Finding and analyzing single-nucleotide polymorphisms with high-density DNA arrays", AMERICAN JOURNAL OF HUMAN GENETICS, UNIVERSITY OF CHICAGO PRESS, CHICAGO,, US, vol. 61, no. 4, SUPPL, 1 October 1997 (1997-10-01), pages 1601, XP002089397, ISSN: 0002-9297 *
WANG D G ET AL: "Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 280, 1998, pages 1077 - 1082, XP002089398, ISSN: 0036-8075 *

Also Published As

Publication number Publication date
WO2001047944A2 (en) 2001-07-05
AU2914501A (en) 2001-07-09
CA2395926A1 (en) 2001-07-05

Similar Documents

Publication Publication Date Title
WO2001047944A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU3719700A (en) Enzymatic dna molecules that contain modified nucleotides
WO2003097794A3 (en) Universal-tagged oligonucleotide primers and methods of use
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU6114700A (en) Novel system for the sequential, directional cloning of multiple dna sequences
AU2002314997A1 (en) Methods for low background cloning of dna using long oligonucleotides
ZA200007270B (en) Novel Nucleotide sequences coding for the zwa2 gene.
AU2001285844A1 (en) Nucleotide sequences which code for the meth gene
AU2001259131A1 (en) Detection of nucleotide sequence variations via the proofreading activity of polymerases
WO2001048245A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001040521A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
EP1551972A4 (en) Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
WO2000029622A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001051670A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO1999046375A3 (en) Human nucleic acid sequences from prostate tissue
WO2001038586A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU2001293821A1 (en) Nucleotide sequences which code for the dead gene
AU2001293741A1 (en) Nucleotide sequences coding for the suga gene
AU2001278509A1 (en) Nucleotide sequences which code for the atr43 gene
WO2001047942A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU2002212232A1 (en) Nucleotide sequences which code for the dps gene
WO2003046143A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU2001291658A1 (en) Nucleotide sequences which code for the ccpa2 gene
AU2001293808A1 (en) Nucleotide sequences which code for the atr61 gene
AU2001289807A1 (en) Nucleotide sequences coding for the pstc2 gene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2395926

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000993615

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 29145/01

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2000993615

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2000993615

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)